Prostioman Capsule
Prostioman Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL09032065T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Manufacturer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Registration period starting
- 2024-03-29
- Published validity end
- 2029-03-29
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| ROYAL JELLY | ROYAL JELLY[40;mg;500;mg] | Gelée royale |
| Rhizoma Dioscorea Opposita | Rhizoma Dioscorea Opposita[20;mg;500;mg] | Not identified |
| Rhizoma curculigo orchioides. | Rhizoma curculigo orchioides.[40;mg;500;mg] | Not identified |
| Radix Polygala Tenuifolia | Radix Polygala Tenuifolia[20;mg;500;mg] | Not identified |
| Radix Morinda Officinalis | Radix Morinda Officinalis[50;mg;500;mg] | Not identified |
| Radix Glycyrrhiza Uralensis. | Radix Glycyrrhiza Uralensis.[25;mg;500;mg] | Not identified |
| Herba Epimedium Sagittatum. | Herba Epimedium Sagittatum.[60;mg;500;mg] | Not identified |
| Herba Cynomorium songaricum. | Herba Cynomorium songaricum.[40;mg;500;mg] | Not identified |
| FRUCTUS CORNUS OFFICINALIS | FRUCTUS CORNUS OFFICINALIS[40;mg;500;mg] | Not identified |
| FRUCTUS CNIDIUM MONNIERI | FRUCTUS CNIDIUM MONNIERI[40;mg;500;mg] | Not identified |
| Fructus Alpinia Oxyphylla | Fructus Alpinia Oxyphylla[20;mg;500;mg] | Not identified |
| Panax ginseng | Panax ginseng[60;mg;500;mg] | Not identified |
| RADIX PUERARIA LOBATA | RADIX PUERARIA LOBATA[25;mg;500;mg] | Not identified |
| Radix Rehmannia Praeparata | Radix Rehmannia Praeparata[20;mg;500;mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- ROYAL JELLY[40;mg;500;mg],Rhizoma Dioscorea Opposita[20;mg;500;mg],Rhizoma curculigo orchioides.[40;mg;500;mg],Radix Polygala Tenuifolia[20;mg;500;mg],Radix Morinda Officinalis[50;mg;500;mg],Radix Glycyrrhiza Uralensis.[25;mg;500;mg],Herba Epimedium Sagittatum.[60;mg;500;mg],Herba Cynomorium songaricum.[40;mg;500;mg],FRUCTUS CORNUS OFFICINALIS[40;mg;500;mg],FRUCTUS CNIDIUM MONNIERI[40;mg;500;mg],Fructus Alpinia Oxyphylla[20;mg;500;mg],Panax ginseng[60;mg;500;mg],RADIX PUERARIA LOBATA[25;mg;500;mg],Radix Rehmannia Praeparata[20;mg;500;mg]
- Valid until
- 2029-03-29
- Registration date
- 2024-03-29
- Published description
- NATURAL PRODUCT
- Licence holder
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Producer
- WHITE HERON PHARMACEUTICAL SDN. BHD.
- Published name
- Prostioman Capsule
- Published reference
- 2008031320082
- Registration number
- MAL09032065T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL09032065T
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- ROYAL JELLY
Read the warning, when it applies and the studies cited
ROYAL JELLY
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Contraindications
Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).
5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Panax ginseng
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.